Research in the Pathogenesis of Hematologic Disorders

描述(由申请人提供)： 这是纽约大学医学院多学科血液学培训计划的续签申请，该计划已经存在了42年以上。该项目旨在13名导师的指导下，为5-6名博士后研究员提供为期两年的研究机会。培训人员包括学术血液学家和血液病理学家，他们拥有活跃的实验室，将基础科学方法应用于血液疾病的研究，以及纽约大学医学院基础科学系的导师。该项目的教职员工之间以及与该机构的其他科学家之间存在着丰富的互动。该机构的临床研究已被美国国立卫生研究院认定为综合癌症中心和艾滋病中心。项目负责人的研究涵盖了这两个领域。新的教职员工加强了该项目的基础科学方向。教职员工在这一框架下工作，为学术界未来的工作培养内科科学家。所有这些项目的一个共同主题是它们对人类疾病的定位。这些目标将通过在实验的设计、执行和评估方面培训有前途的候选人来实现，以便他们可以加入基础血液学研究和翻译血液学研究的学术内科科学家的行列。相关性(见说明)：随着国家人口的老龄化，我们更有必要对血液疾病的内科科学家进行基础和转化性研究方面的培训。纽约大学医学院的培训计划将继续这一使命。

DESCRIPTION (provided by applicant): This is a renewal application for a multidisciplinary hematology training program at New York University School of Medicine which has been in existence for over 42 years. The program is designed to provide two- year research opportunities for 5-6 post-doctoral fellows under the guidance of a faculty of 13 mentors. The training faculty consists of academic hematologists and hematopathologists with active laboratories applying basic science methods to the study of hematologic disorders as well as mentors of the basic science departments of NYU School of Medicine. There is abundant interaction among the faculty members within the program as well as with other scientists at this institution. The clinical research at this institution has been recognized by the NIH in its designation as a Comprehensive Cancer Center and an AIDS Center. The program director's research spans both areas. New faculty members have strengthened the basic science orientation of the program. The faculty works with this framework to train physician-scientists for future work in the academic community. A common theme of all the projects is their orientation to human disease. These aims will be accomplished by training promising candidates in the design, execution and evaluation of experiments so that they may join the ranks of academic physician-scientists in basic as well as translational hematology research. RELEVANCE (See instructions): As the Nation's population is aging, it is becomes even more necessary that we train physician-scientists in hematologic disorders in basic and translational research. The training program at NYU School of Medicine will continue that mission.